4//SEC Filing
Schroeder Theodore R 4
Accession 0000950170-25-054886
CIK 0001783183other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:44 PM ET
Size
7.3 KB
Accession
0000950170-25-054886
Insider Transaction Report
Form 4
Schroeder Theodore R
Director
Transactions
- Award
Common Stock
2025-04-16+21,000→ 21,000 total - Award
Common Stock (Right to Buy)
2025-04-16+35,000→ 35,000 totalExercise: $4.23Exp: 2035-04-15→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted on April 16, 2025. One-third (1/3) of the total number of RSUs granted vest on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The stock option will vest with respect to one-third (1/3) of the shares of common stock on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001378690
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 5:44 PM ET
- Size
- 7.3 KB